US Equity Value (0P0001HV5H)

Key Updates

US Equity Value is recovering from the November correction, gaining 2.75% since the last report to $1667.38, returning the fund to late October levels. The recovery is occurring amid M&A sector activity, including Abbott's major $21 billion acquisition of Exact Sciences, which indicates increased risk appetite in the market.

Current Trend

The fund is demonstrating steady recovery following the mid-November correction, showing 2.73% growth over the last 5 days. Six-month returns stand at an impressive 11.89%, confirming the long-term attractiveness of the value investing strategy. The current level of $1667.38 is near the historical highs reached in October.

Investment Thesis

The value strategy continues to meet expectations amid growing corporate deal activity and capital rotation into undervalued assets. Large M&A transactions, such as Abbott's acquisition of Exact Sciences, provide additional support for the value segment, as they demonstrate companies' willingness to pay premiums for quality assets.

Thesis Status

The investment thesis is strengthening. The recovery from the correction confirms the strategy's resilience, while increased M&A activity creates additional growth catalysts. The six-month return of 11.89% exceeds most index strategies, validating the correctness of the chosen approach to investing in undervalued assets.

Key Drivers

The primary growth driver is the intensification of the mergers and acquisitions market, including Abbott's $21 billion acquisition of Exact Sciences. Concurrently, there is a correction in high-risk sectors such as quantum computing, where IonQ shares lost 31% over the month, facilitating capital rotation into more stable value assets.

Technical Picture

The fund has successfully tested the support level around $1622 and is demonstrating upward momentum with a target level of $1680-1700. RSI is in the neutral zone, leaving room for further growth. Trading volumes remain stable, confirming the organic nature of the current recovery without signs of speculative activity.

Bull Case

• Intensification of the M&A market creates additional support for undervalued assets, as demonstrated by Abbott's $21 billion deal
• Capital rotation from high-risk sectors into stable value assets amid correction in quantum technologies
• Solid six-month performance of +11.89% confirms strategy effectiveness in current market conditions
• Technical bounce from the $1622 support level opens the path to testing historical highs
• Development of the asset tokenization market creates new diversification opportunities, as shown by Securitize's activity

Bear Case

• High current levels near historical highs limit further upside potential in the near term
• Legal proceedings regarding major deals, including investigation into price fairness for Exact Sciences, create uncertainty
• Volatility in individual sectors such as media, where Warner Bros' 122% gain may be unsustainable
• Risk of correction upon reaching technical resistance levels in the $1680-1700 zone
• Overall market uncertainty may negatively impact risk appetite and M&A activity